| 1,4-Butanediol diglycidyl ether | (Ti-HABDDE) |
| 1-Phenyl-3-methyl-5-pyrazolone | (PMP) |
| 2,4-Dinitrochlorobenzene | (DNCB) |
| 2-Chloro-N,N-diethylethylamine | (DE-AE) |
| 3-Hydroxy-3-methylglutaryl coenzyme A | (HMG-CoA) |
| 45S5 Bioglass | (BG) |
| 5-Fluorouracil | (5-FU) |
| Acetylsalicylic acid (aspirin) | (ASA) |
| Adamantane-modified hyaluronic acid | (HAD) |
| Alpha-smooth muscle actin, commonly known as actin alpha 2, Acta2 | α-SMA |
| Aptamer | AS-42 |
| Arabinogalactan | (AG) |
| Asialoglycoprotein receptor | (ASGPR-1) |
| Atomic force microscopy | (AFM) |
| Atopic dermatitis | (AD) |
| Bacterial cellulose | (BC) |
| Beta-cyclodextrin-modified silk fibroin | (SCD) |
| Bone morphogenetic protein 2 | BMP2 |
| Cancer drug methotrexate | (MTX) |
| Carbon tetrachloride | (CCl4) |
| Carboxymethyl starch | (CMS) |
| Carboxymethyl pullulan | (CMP) |
| Carboxymethyl dextran | (CMD) |
| Cefazolin/chitosan | (P-Z@C) |
| Cefazolin/chitosan crosslinked by calcium phosphate | (P-Z@C/CP) |
| Chitosan/carboxymethyl pullulan | (CCMP) |
| Chitosan/carboxymethyl pullulan polyelectrolyte complex | (PEC) |
| Chitosan/carboxymethyl pullulan polyelectrolyte complex (PEC) loaded with 45S5 Bioglass | (CCMPBG) |
| Cisplatin–arabinogalactan–aptamer | (Cis-AG-Ap) |
| Collagen-1-alpha | COL1A1 |
| Corn starch acetates | (SA) |
| Crosslinked MC-loaded nanocells | (MC@(ODA-CMD)CL |
| DEAE-modified pullulan | (PULL-DEAE) |
| Defensive Antibacterial Coating | DAC® |
| Degree of methoxylation | (DM) |
| Dextran-coated cerium-doped hydroxyapatite (Ca10−xCex(PO4)6(OH)2) with x = 0.05 | (5CeHAp-D) |
| Dextran-coated cerium-doped hydroxyapatite (Ca10-−xCex(PO4)6(OH)2) with x = 0.1 | (10CeHAp-D) |
| Differential refractive index detector | (RID) |
| Divinyl sulfone | (Ti-HADVS) |
| Dosage forms | (FDs) |
| Drug Delivery System | (DDS) |
| Dynamic light scattering | (DLS) |
| D-α-tocopheryl polyethylene glycol succinate | (TPGS) |
| Encapsulation efficiency | (EE) |
| Endosomal cleavable peptide | (GFLG) |
| Energy-dispersive X-ray spectroscopy | (EDX) |
| Essential oil | (EO) |
| Fibrosis-mediating proteins | PDGFRB, TIMP-1, TLR-9 and TGFβ |
| Folate receptors | (FR) |
| Folic acid | (FA) |
| Fourier transform infrared spectroscopy | (FTIR) |
| Gas chromatography | (GC) |
| Gas chromatography–mass spectrometry | GC-MS |
| Gastrointestinal | (GI) |
| Gel permeation chromatography | GPC |
| Glow discharge optical emission spectroscopy | (GDOES) |
| Grafted copolymer pullulan–DEAE-g-poly(Z-1-lysine) | (PULL–DEAE-g-PZLL) |
| Heat shock proteins | (HSP) |
| High-performance liquid chromatography | (HPLC) |
| Highly methoxylated pectin | (HMP) |
| High-performance anion exchange chromatography combined with pulsed amperometric detection | (HPAEC-PAD) |
| High-performance capillary electrophoresis | (HPCE) |
| High-performance exclusion chromatography | (HPSEC) |
| High-performance gel permeation chromatography | (HPGPC) |
| Human liver cancer cell line | (HepG2) |
| Human serum albumin | (HSA) |
| Hyaluronic acid | (HA) |
| Hydroxypropyl methylcellulose | (HPMC) |
| Hypromellose Acetate Succinate | (HPMCAS) |
| Ibuprofen | (IBU) |
| Lactobionic acid | (LA) |
| Lactobionic acid–adipic acid dihydrazide conjugate | (LAD) |
| Lauroylated AG | (LAG) |
| Lauroylated PL | (LPL) |
| Layer-by-layer | (LbL) |
| Levofloxacin | (Levo) |
| Local drug delivery | (LDD) |
| Mammalian cells | CHO |
| Mass spectrometry | (MS) |
| Matrix-assisted pulsed laser evaporation | (MAPLE) |
| MC-loaded CMD-based nanocells coated on a MAO-Ti surface | (MC@(ODA-CMD)CL-Ti) |
| Metallographic microscopy | (MM) |
| Microarcoxidized titanium | (MAO-Ti) |
| Minimum inhibitory concentration | (MIC) |
| Minocycline | (MC) |
| Molecular weights | (MW) |
| Multiangle laser scattering detector | (MALLS) |
| Nanocomposites | (NCs) |
| Nanoparticles | (NPs) |
| Nanostructured lipid carriers | (NLCs) |
| N-carbobenzyloxy-1-lysine-N-carboxyanhydride | (Lys(Z)-NCA) |
| Nuclear magnetic resonance | (NMR) |
| Octadecylamine | (ODA) |
| Palmitoylated PL | (PPL) |
| Paper chromatography | (PC) |
| Platelet-derived growth factor receptor beta | PDGFRB |
| Platelet-derived growth factor receptor beta | (PDGFRB) |
| Poly(glycerol adipate) | (PGA) |
| Poly(methyl methacrylate) | (PMMA) |
| Polyamide 12 | (PA12) |
| Polycaprolactone | (PCL) |
| Polysaccharide arabinogalactan | (AG) |
| Pomegranate peel extract | (PPE) |
| Porous starch | (PS) |
| Pullulan | (PL) |
| Pullulan–polyethyleneimine | (Pul-PEI) |
| Pullulan–tris(2-aminoethyl)amine | (Pul-TAEA) |
| Pulsed direct current | (DC) |
| Quercetin | (Quer) |
| Salicylic acid | (SA) |
| Scanning electron microscopy | (SEM) |
| Silver nanoparticles | (AgNPs) |
| Staphylococcus aureus | (S. aureus) |
| The most biologically relevant receptor | (CD44) |
| The receptor for hyaluronan-mediated motility | (RHAMM) |
| Thin-layer chromatography | (TLC) |
| Tissue inhibitors of metalloproteinases | (TIMPs) |
| Transmission electron microscopy | (TEM) |
| Triblock copolymer | (Pluronic F127) |
| Palmitoylated AG | (PAG) |